Design and synthesis of simple macrocycles active against vancomycin-resistant Enterococci (VRE)

被引:11
|
作者
Jia, Yanxing
Ma, Nianchun
Liu, Zuosheng
Bois-Choussy, Michele
Gonzalez-Zamora, Eduardo
Malabarba, Adriano
Brunati, Cristina
Zhu, Jieping [1 ]
机构
[1] CNRS, Inst Chim Subst Nat, F-91198 Gif Sur Yvette, France
[2] Univ Autonoma Metropolitana Iztapalapa, Mexico City 09340, DF, Mexico
[3] Vicuron Pharmaceut, Italy Res Ctr, I-21040 Gerenzano, VA, Italy
关键词
antibiotics; biaryl ether; glycopeptides; macrocycles; SNAr; vancomycin; ALA-D-LAC; GLYCOPEPTIDE ANTIBIOTICS; STRUCTURAL MODIFICATIONS; CYCLOPEPTIDE ALKALOIDS; ANTIBACTERIAL ACTIVITY; STAPHYLOCOCCUS-AUREUS; REDUCTIVE HYDROLYSIS; TEICOPLANIN AGLYCON; BINDING; DERIVATIVES;
D O I
10.1002/chem.200600137
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
16-membered meta,para-cyclophanes mimicking the vancomycin binding pocket (D-O-E ring) were designed and synthesized. The structural key features of these biaryl ether containing macrocycles are (1) the presence of P-amino-a-hydroxy acid or alpha,beta-diamino acid as the C-terminal component of the cyclopeptide and (2) the presence of a hydrophobic chain or lipidated aminoglucose at the appropriate position. Cycloetherification by an intramolecular nucleophilic aromatic substitution reaction (SNAr) is used as the key step for the construction of the macrocycle. The atropselectivity of this ring-closure reaction is found to be sensitive to the peptide backbone and chemoselective cyclization (phenol versus primary amine) is achievable. Glycosylation of phenol was realized with freshly prepared 3,4,6-tri-O-acetyl-2-N-lauroyl-2-amino-2-deoxy-alpha-D-glucopyranosyl bromide under phase-transfer conditions. Minimum inhibitory concentrations for all of the derivatives are measured by using a standard microdilution assay, and potent bioactivities against both sensitive and resistant strains are found for some of these compounds (MIC (minimum inhibitory concentration) = 4 mu g mL(-1) against VRE). From these preliminary SAR studies, it was anticipated that both the presence of a hydrophobic substituent and an appropriate structure of the macrocycle were required for this series of compounds to be active against VRE.
引用
收藏
页码:5334 / 5351
页数:18
相关论文
共 50 条
  • [1] Design and Synthesis of 16-Membered Cyclopeptides Active Against Vancomycin-resistant Enterococci (VRE)
    Zhu, Jieping
    CHIMIA, 2013, 67 (12) : 916 - 920
  • [2] Design and synthesis of macrocycles active against vancomycin-resistant enterococci (VRE): the interplay between D-Ala-D-Lac binding and hydrophobic effect
    Ma, NC
    Jia, YX
    Liu, ZS
    Gonzalez-Zamora, E
    Bois-Choussy, M
    Malabarba, A
    Brunati, C
    Zhu, J
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (03) : 743 - 746
  • [3] Importance of the Structure of Vancomycin Binding Pocket in Designing Compounds Active Against Vancomycin-resistant Enterococci (VRE)
    Yanxing Jia
    Michèle Bois-choussy
    Adriano Malabarba
    Cristina Brunati
    Jieping Zhu
    The Journal of Antibiotics, 2006, 59 : 543 - 552
  • [4] Importance of the structure of vancomycin binding pocket in designing compounds active against vancomycin-resistant enterococci (VRE)
    Jia, Yanxing
    Bois-Choussy, Michele
    Malabarba, Adriano
    Brunati, Cristina
    Zhu, Jieping
    JOURNAL OF ANTIBIOTICS, 2006, 59 (09): : 543 - 552
  • [5] Optimizing therapy for vancomycin-resistant enterococci (VRE)
    Linden, Peter K.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 28 (06) : 632 - 645
  • [6] Vancomycin-resistant enterococci (VRE): transmission and control
    Tacconelli, Evelina
    Cataldo, Maria A.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 31 (02) : 99 - 106
  • [7] Vancomycin-resistant enterococci (VRE): a reason to isolate?
    Maria J. G. T. Vehreschild
    Miriam Haverkamp
    Lena M. Biehl
    Sebastian Lemmen
    Gerd Fätkenheuer
    Infection, 2019, 47 : 7 - 11
  • [8] Vancomycin-resistant enterococci (VRE): a reason to isolate?
    Vehreschild, Maria J. G. T.
    Haverkamp, Miriam
    Biehl, Lena M.
    Lemmen, Sebastian
    Faetkenheuer, Gerd
    INFECTION, 2019, 47 (01) : 7 - 11
  • [9] Nurses' experience with vancomycin-resistant enterococci (VRE)
    Mitchell, A
    Cummins, T
    Spearing, N
    Adams, J
    Gilroy, L
    JOURNAL OF CLINICAL NURSING, 2002, 11 (01) : 126 - 133
  • [10] Nitrofurantoin is active against vancomycin-resistant enterococci
    Zhanel, GG
    Hoban, DJ
    Karlowsky, JA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) : 324 - 326